SK

Syed Kalbe Abed Ali Mash Hady

Active Director Director DIN 10202380
DIN 10202380 First appointment Jun 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Syed Kalbe Abed Ali Mash Hady

Data last updated:

Syed Kalbe Abed Ali Mash Hady is a Director at Dr. Jan Healthcare Private Limited (since 2023).

DIN 10202380
Primary Designation Director
First Appointment 13 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Jan Healthcare Private Limited U86909TS2023PTC174075
Director13 Jun 20232023Active

Board colleagues of Syed Kalbe Abed Ali Mash Hady

Directorship timeline

Open interactive timeline →
Dr. Jan Healthcare Private Limited
Premium access

Shareholding and investment profile for Syed Kalbe Abed Ali Mash Hady

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Kalbe Abed Ali Mash Hady

Syed Kalbe Abed Ali Mash Hady currently holds 1 directorship: Dr. Jan Healthcare Private Limited (Director, since 13 Jun 2023).

Syed Kalbe Abed Ali Mash Hady was first appointed on 13 Jun 2023 as Director at Dr. Jan Healthcare Private Limited.

The current boards of Syed Kalbe Abed Ali Mash Hady's companies include Jai Sekhar Reddy Gudimetla (Dr. Jan Healthcare Private Limited), Nuthan Pothula (Dr. Jan Healthcare Private Limited), Venkata Naga Lakshmi Sumalatha Pothula (Dr. Jan Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available